The Government of Canada highlights progress on breast cancer screening research and implementation in Canada

News release Ottawa, Ontario | Public Health Agency of Canada Breast cancer is one of the most common forms of cancer and the second leading cause of cancer-related deaths among women. One in eight women in Canada is expected to be diagnosed with breast cancer in their lifetime. Raising awareness of breast cancer screening, which aims to detect cancer at an earlier, more treatable stage, is a priority for the Government of Canada. The Government of Canada is committed to supporting the health of women by addressing knowledge gaps in breast cancer screening and prevention. The Public Health Agency of Canada (PHAC), in collaboration with federal, provincial and territorial experts and stakeholders, hosted the event Closing the Gap: Action for Equity in Breast Cancer Screening. This event discussed improving accessibility and inclusivity in breast cancer screening, especially for underserved populations. Participants shared lessons learned and best practices that will be compiled into a resource guide that will be shared broadly across all jurisdictions to help improve equitable implementation of breast cancer screening in Canada. PHAC is working closely with Statistics Canada to conduct analyses of national cancer trends, including examining differences in breast cancer rates based on where people live, their age and ethnicity. This will support informed and data driven breast cancer screening policy. The Canadian Institutes of Health Research (CIHR) and partners have developed a multi-disciplinary roadmap that identifies research gaps for breast cancer screening and provides recommendations to guide future research activities in Canada. The roadmap summarizes what was heard from partners alongside key research areas and strategies to support breast cancer research in Canada. The Government of Canada is also working directly with our partners, like the Canadian Partnership for Tomorrow’s Health and the Canadian Cancer Society, to generate better data to inform breast cancer screening practices and raise awareness of its importance in Canada. Together, these initiatives support collaborative and scientific research, data collection, and public health guidance for breast cancer screening in Canada. Quotes “I would like to thank our partners and stakeholders for their commitment to overcome barriers and improve access to breast cancer screening in Canada. Awareness and access to breast cancer screening will make life changing differences for the health of Canadians.” The Honourable Mark Holland Minister of Health “Breast cancer touches the lives of so many, either through a personal diagnosis or that of a loved one. Through this work and the dedication of our partners, we are taking important steps to safeguard women’s physical and mental health.” The Honourable Ya’ara Saks Minister of Mental Health and Addictions and Associate Minister of Health Quick facts Breast cancer is the second most common cancer in women living in Canada, after non-melanoma skin cancer. While it can also be found in men, male breast cancer is a very rare occurrence. Breast cancer screening is used to detect cancer in people who do not have any signs or symptoms. This differs from diagnostic testing, which is used when someone does have signs or symptoms (e.g., a lump). The Government of Canada recognizes and respects that each province and territory has unique needs and different approaches to breast cancer screening. Provincial and territorial governments are responsible for diagnosis, treatment, services, programming and education. Associated links Canadian Cancer Society – Get your mammogram Canadian Partnership For Tomorrow’s Health Government of Canada invests in breast cancer research and public awareness Contacts Matthew Kronberg Press Secretary Office of the Honourable Mark Holland Minister of Health 343-552-5654 Callum Haney Press Secretary Office of the Honourable Ya’ara Saks Minister of Mental Health and Addictions and Associate Minister of Health 343-576-4407 Media Relations Health Canada 613-957-2983 media@hc-sc.gc.ca Public Inquiries 613-957-2991 1-866-225-0709

Upcoming Webinar – CanPath’s Genomic Landscape

Webinar: CanPath’s genomic data landscape: Insights from Ontario and Quebec Canada’s largest genomic data resource just got bigger … how will you use it? ?? CanPath now offers even more genotyping data from the Ontario Health Study (OHS) and CARTaGENE (Quebec), creating new opportunities to explore genetic ancestry, disease risk, and innovative research approaches. Join Dr. Philip Awadalla and Dr. Guillaume Lettre on Tuesday, March 2, at 11:00 AM EDT as they describe: Ontario’s latest genotyping data & research applications Genetic ancestry, the French Canadian founder effect & whole genome sequencing Emerging tools like liquid biopsy, cell-free DNA & single-cell studies Registration: https://bit.ly/41mOPq1

Webinar – Understanding the connections between air pollution and rheumatic disease

Join us for an upcoming CanPath webinar that considers the connections between air pollution and rheumatic disease. February 20, 2025   ~   12pmEST/1pmAST Registration: https://bit.ly/40YZNBx About the webinar Join Dr. Sasha Bernatsky, a leading researcher in rheumatic disease and environmental health, as she delves into how environmental exposures impact autoimmunity and inflammation. Drawing on her extensive work with CanPath, Dr. Bernatsky has demonstrated potential associations between air pollutants, including PM2.5, and autoimmunity and rheumatic diseases. In this session, Dr. Bernatsky will also preview her new research on the impact of wildfire smoke and temperature extremes on rheumatic diseases in Canada, supported by recent CIHR funding. Researchers interested in environmental health, autoimmune diseases, and leveraging population-based data for innovative studies won’t want to miss this opportunity to gain valuable insights and explore future directions in the field. About the presenter Dr. Sasha Bernatsky Sasha Bernatsky, MD PhD, is a rheumatologist, a James McGill Professor of Medicine at McGill University and a Senior Scientist of the Centre for Health Outcomes Research at the Research Institute of the McGill University Health Centre.  Dr. Bernatsky is also affiliated with the McGill Environmental Epidemiology Research Group, a network with expertise in pharmacology/toxicology, and environmental sciences. She is a member of the Canadian Urban Environmental Health Research Consortium (CANUE), the Systemic Lupus International Collaborating Clinics (SLICC), and the Canadian Network for Improved Outcomes in SLE (CaNIOS). Her research focuses mainly on outcomes in rheumatic diseases, pharmacoepidemiology, and air pollution’s effects on health.

New Article – Quality of Non-Surgical and Non-Pharmacological Knee Osteoarthritis Care in the Maritimes

Congratulations to Aleksandra Budarick, Dr. Cheryl Hubley-Kozey, Dr. Rebecca Moyer and team on their new article, “Quality of Non-Surgical and Non-Pharmacological Knee Osteoarthritis Care in the Maritimes.” Participants with osteoarthritis from Atlantic PATH were invited to participate in an ancillary study about the Current Management and Health Care Quality for Patients with Knee and Hip Osteoarthritis. Over half of individuals with mild-to-moderate knee osteoarthritis did not receive recommended core treatments in the Maritimes, highlighting a need to improve care for this patient group.

Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease

The Global Biobank Meta-analysis Initiative (GBMI) unites 24 biobanks, including CanPath and its regional cohorts, with data from over 2.2 million people, to power global genetic discovery. By integrating diverse genetic info, GBMI improves disease risk prediction, advances personalized medicine, and boosts discoveries. CanPath contributes Canadian data, adding diversity and impact! Together, they’ve harmonized data, improved data on 14 diseases, and accelerated drug target discovery. The future? More inclusivity, better data sharing, and deeper disease insights.

CIHR Team Grants: Bringing Biology to Cancer Prevention

Team Grants — Bringing Biology to Cancer Prevention  This opportunity is led by the CIHR Institute of Cancer Research (CIHR-ICR) in collaboration with the CIHR Institutes of: Aging (CIHR-IA), Gender and Health (CIHR-IGH), Nutrition, Metabolism and Diabetes (CIHR-INMD), Population and Public Health (CIHR-IPPH), and in partnership with the BioCanRx, Canadian Cancer Society (CCS), Cancer Research Society (CRS), Japan Agency for Medical Research and Development (AMED) – Adopting Sustainable Partnerships for Innovative Research Ecosystem (ASPIRE), and the Terry Fox Research Institute (TFRI). This funding opportunity aims to unite interdisciplinary research teams to advance the biological and mechanistic understanding of cancer etiology, genesis, and risk to identify new targets and approaches for cancer prevention, risk reduction and early detection. CanPath and Atlantic PATH can provide letters of support for applicants using our data and biological samples. Registration deadline: April 1, 2025 Application deadline: June 19, 2025 Additional details: https://bit.ly/3PtR8SC Upcoming webinars: January 29, 12:30-2:00 PM ET | Register here. February 5, 12:30-2:00 PM ET | Register here  

2024/25 Scotia Scholars Undergraduate and Summer Research Awards

From Research Nova Scotia: The Scotia Scholars Award provides financial support to students with exceptional potential who are, or wish to be, engaged in a health research project at participating institutions. Applications for the undergraduate awards are now open to students at Cape Breton University, Université Sainte-Anne, and University of King’s College, and applications for the summer research awards are now open to students at Nova Scotia Community College (NSCC). This award supports the growth and retention of highly skilled individuals who are advancing and translating knowledge in one or more of RNS’s health mission areas: disease detection, diagnosis, treatment, and prevention, strengthening our health care delivery system, caring for vulnerable populations, preventing negative impacts to health and wellbeing. Applications are due January 30, 2025 at 1:00pm (AST). Additional details: https://researchns.ca/ssa      

New environmental exposure data added to CanPath: Greenness, air quality, and accessibility

CanPath is excited to continue collaborating with the CIHR-funded Canadian Urban Environmental Health Research Consortium (CANUE) by linking a third round of environmental exposure data to the national harmonized CanPath datasets. Since 2016, CANUE has gathered and standardized environmental exposure data on air and noise pollution, land use, community amenities, green spaces, climate, and socioeconomic conditions. This data is then linked to Canadian cohort studies and health databases. CANUE and CanPath conducted their first linkage activity in May 2019, followed by a second round of linkage in June 2021. The CANUE environmental exposure data was merged with CanPath’s national harmonized datasets using participants’ 6-digit residential postal codes and are available to researchers. This year, 17 new datasets were added to the existing 27 environmental exposure datasets, providing additional measures of greenness, air quality, accessibility, and socioeconomic factors. “The key strength of CanPath’s collaboration with CANUE is the wide-ranging environmental exposures captured, allowing for diverse analyses beyond disease prevention, including developing healthier environments,” says Sheraz Cheema, CanPath Data Manager. “This longitudinal data is invaluable for researchers assessing prolonged exposure impacts on health. CanPath aims to continue collecting data for 20-30 years, increasing its value over time.” Green spaces and vegetation CANUE develops data on neighbourhood greenness from two main sources. First, the MODIS satellite program has provided a consistent measure of greenness across Canada from 2000 to 2023, using a single sensor to ensure data reliability at a 250-meter resolution. Greenness is measured using the Normalized Difference Vegetation Index (NDVI) scale to characterize an area’s vegetation density. Secondly, the Landsat-based Vegetative Greenness Fractions dataset offers a finer 30-meter resolution and measures greenness. This dataset can even detect roads and buildings beneath tree canopies, offering a more detailed view. “This could be an excellent opportunity to study those vertical layers,” says Joey Syer, CANUE Data Director, “as opposed to just the horizontal layer of greenness.” New datasets linked to CanPath include: Advanced Very High-Resolution Radiometer (AVHRR) Normalized Difference Vegetation Index (NDVI) (2000-2013) Landsat – Greenest Pixel (2000-2017) Landsat – Growing Season (2000-2019) Moderate Resolution Imaging Spectroradiometer (MODIS) – Annual Max (2000-2023) MODIS – Annual Mean (2000-2023) MODIS – Growing Season Max (2000-2023) MODIS – Growing Season Mean (2000-2023) Air quality One of the relatively new datasets in CANUE’s data holdings is the Canadian Optimized Statistical Smoke Model (CanOSSEM), which Naman Paul and colleagues developed at the BC Centre for Disease Control. This dataset estimates fine particulate matter (PM2.5) and is optimized for wildfire smoke. CANUE has data from 2010 to 2022 at daily, monthly, and annual scales, and it comes on a 5 km by 5 km grid. “The variation within those five kilometres is probably not much,” says Joey, “but the fact that this data covers all of Canada makes this an unparalleled resource in terms of space and time attributes. It’s really deserving of usage and study.” New datasets include: Fine Particulate Matter (PM2.5 v4) (2000-2020) Fine Particulate Matter (PM2.5 v5) (2000-2021) Smoke Exposure (PM2.5 v2) (2010-2022) Accessibility and transportation The CanPath data assets have also been updated with many new datasets in the ‘neighbourhoods’ domain. These include the Canadian Bikeway Comfort and Safety Classification System (Can-BICS) metrics, which measure the quantity and quality of cycling infrastructure in Canadian communities, and several spatial accessibility indicators, which provide information on access to different services and amenities. “By linking these and other CANUE datasets to CanPath data, we can explore how the built environment affects chronic health conditions like never before,” says Dr. Dany Doiron, CANUE Managing Director. New datasets include: Spatial Accessibility Measures (2021) Public Transportation (2019) Canadian Bikeway Safety Metrics (Can-BICS) (2021) Street Connectivity (2019) Other socioeconomic factors Many other socioeconomic factors can provide valuable insights into how the built environment and access to healthy food impact chronic diseases, including cancer risk and prevention. Dr. Trevor Dummer, CanPath National Scientific Co-Director, spoke about his role as a health geographer: “My interest in cancer prevention is understanding how the built environment and natural environment influences our cancer risk. This includes how our behaviours, such as physical activity or access to healthy food, are impacted by our geography. CanPath, as a longitudinal cohort linked to CANUE geospatial information and cancer registry data, has vast potential for epidemiological analysis to identify cancer risk factors and support prevention.” New datasets include: Building Density (2019) Dwellings Needing Repair (2016-2021) Canadian Food Environment Dataset (Can-FED) (2018)

New Article – Investigating Skin Cancer Risk and Sun Safety Practices Among LGBTQ+ Communities in Canada

Congratulations to Dr. François Lagacé, Dr. Ivan Litvinov and team on their new article, “Investigating Skin Cancer Risk and Sun Safety Practices Among LGBTQ+ Communities in Canada.” Participants from Atlantic PATH and the Manitoba Tomorrow Project were invited to participate in the SunFit study led by Dr. Litvinov at McGill University. Skin cancer prevention requires effective sun safety practices. Previous studies have shown that LGBTQ+ individuals exhibit lower sunscreen use and higher tanning bed usage compared to their non-LGBTQ+ counterparts. This SunFit study is the first to assess skin cancer risk factors, sun-protective behaviors, and skin cancer concerns among LGBTQ+ participants across Canada.